Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction.

Goldstein I, McCullough AR, Jones LA, Hellstrom WJ, Bowden CH, Didonato K, Trask B, Day WW.

J Sex Med. 2012 Apr;9(4):1122-33. doi: 10.1111/j.1743-6109.2011.02629.x. Epub 2012 Jan 16.

PMID:
22248153
2.

Efficacy of Avanafil 15 Minutes after Dosing in Men with Erectile Dysfunction: A Randomized, Double-Blind, Placebo Controlled Study.

Hellstrom WJ, Kaminetsky J, Belkoff LH, Goldstein I, Tursi JP, Uy J, Peterson CA, Bowden CH, Day WW.

J Urol. 2015 Aug;194(2):485-92. doi: 10.1016/j.juro.2014.12.101. Epub 2015 Jan 12.

PMID:
25591992
3.

A phase 3, placebo controlled study of the safety and efficacy of avanafil for the treatment of erectile dysfunction after nerve sparing radical prostatectomy.

Mulhall JP, Burnett AL, Wang R, McVary KT, Moul JW, Bowden CH, DiDonato K, Shih W, Day WW.

J Urol. 2013 Jun;189(6):2229-36. doi: 10.1016/j.juro.2012.11.177. Epub 2012 Dec 3.

PMID:
23219537
4.

Efficacy and tolerability of udenafil in Turkish men with erectile dysfunction of psychogenic and organic aetiology: a randomized, double-blind, placebo-controlled study.

Ortaç M, Çayan S, Çalişkan MK, Yaman MÖ, Okutucu TM, Semerci MB, Altay AB, Balbay MD, Özcan MF, Kadioğlu A.

Andrology. 2013 Jul;1(4):549-55. doi: 10.1111/j.2047-2927.2013.00085.x.

5.

Efficacy and safety of oral mirodenafil in the treatment of erectile dysfunction in diabetic men in Korea: a multicenter, randomized, double-blind, placebo-controlled clinical trial.

Park HJ, Choi HK, Ahn TY, Park JK, Chung WS, Lee SW, Kim SW, Hyun JS, Park NC.

J Sex Med. 2010 Aug;7(8):2842-50. doi: 10.1111/j.1743-6109.2010.01888.x. Epub 2010 Jul 7.

PMID:
20626604
6.

Efficacy and safety of avanafil for treating erectile dysfunction: results of a multicentre, randomized, double-blind, placebo-controlled trial.

Zhao C, Kim SW, Yang DY, Kim JJ, Park NC, Lee SW, Paick JS, Ahn TY, Moon KH, Chung WS, Min KS, Suh JK, Hyun JS, Park K, Park JK.

BJU Int. 2012 Dec;110(11):1801-6. doi: 10.1111/j.1464-410X.2012.11095.x. Epub 2012 Mar 27.

7.

An open-label, long-term evaluation of the safety, efficacy and tolerability of avanafil in male patients with mild to severe erectile dysfunction.

Belkoff LH, McCullough A, Goldstein I, Jones L, Bowden CH, DiDonato K, Trask B, Day WW.

Int J Clin Pract. 2013 Apr;67(4):333-41. doi: 10.1111/ijcp.12065.

PMID:
23521325
8.

Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes mellitus.

Goldstein I, Jones LA, Belkoff LH, Karlin GS, Bowden CH, Peterson CA, Trask BA, Day WW.

Mayo Clin Proc. 2012 Sep;87(9):843-52. doi: 10.1016/j.mayocp.2012.06.016. Epub 2012 Aug 1.

9.

The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction.

Paick JS, Kim SW, Yang DY, Kim JJ, Lee SW, Ahn TY, Choi HK, Suh JK, Kim SC.

J Sex Med. 2008 Apr;5(4):946-53. doi: 10.1111/j.1743-6109.2007.00723.x. Epub 2008 Jan 21.

PMID:
18221288
10.

Avanafil for male erectile dysfunction: a systematic review and meta-analysis.

Cui YS, Li N, Zong HT, Yan HL, Zhang Y.

Asian J Androl. 2014 May-Jun;16(3):472-7. doi: 10.4103/1008-682X.123670. Review.

11.

Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study.

McMahon CG, Giuliano F, Dean J, Hellstrom WJ, Bull S, Tesfaye F, Sharma O, Rivas DA, Aquilina JW.

J Sex Med. 2013 Sep;10(9):2312-25. doi: 10.1111/jsm.12236. Epub 2013 Jul 11.

PMID:
23845016
12.

Efficacy and safety of once-daily tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline.

Shabsigh R, Seftel AD, Kim ED, Ni X, Burns PR.

J Sex Med. 2013 Mar;10(3):844-56. doi: 10.1111/j.1743-6109.2012.02898.x. Epub 2012 Oct 4.

PMID:
23035781
13.

Efficacy of udenafil for the treatment of erectile dysfunction up to 12 hours after dosing: a randomized placebo-controlled trial.

Park HJ, Park JK, Park K, Min K, Park NC.

J Sex Med. 2010 Jun;7(6):2209-16. doi: 10.1111/j.1743-6109.2010.01817.x. Epub 2010 Apr 19.

PMID:
20412426
14.

A randomized, double-blind, placebo-controlled, parallel study to assess the efficacy and safety of once-a-day tadalafil in men with erectile dysfunction who are naïve to PDE5 inhibitors.

Montorsi F, Aversa A, Moncada I, Perimenis P, Porst H, Barker C, Shane MA, Sorsaburu S.

J Sex Med. 2011 Sep;8(9):2617-24. doi: 10.1111/j.1743-6109.2011.02353.x. Epub 2011 Jun 27.

PMID:
21707928
15.

Men with mild erectile dysfunction benefit from sildenafil treatment.

Bénard F, Carrier S, Lee JC, Talwar V, Defoy I.

J Sex Med. 2010 Nov;7(11):3725-35. doi: 10.1111/j.1743-6109.2010.02015.x. Epub 2010 Oct 4.

PMID:
20946161
16.

Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.

Eardley I, Gentile V, Austoni E, Hackett G, Lembo D, Wang C, Beardsworth A.

BJU Int. 2004 Oct;94(6):871-7.

17.

A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Therapeutic Confirmatory Study to Evaluate the Safety and Efficacy of Avanafil in Korean Patients with Erectile Dysfunction.

Park HJ, Kim SW, Kim JJ, Lee SW, Paick JS, Ahn TY, Park K, Park JK, Park NC.

J Korean Med Sci. 2017 Jun;32(6):1016-1023. doi: 10.3346/jkms.2017.32.6.1016.

18.

The efficacy and safety of udenafil [Zydena] for the treatment of erectile dysfunction in hypertensive men taking concomitant antihypertensive agents.

Paick JS, Kim SW, Park YK, Hyun JS, Park NC, Lee SW, Park K, Moon KH, Chung WS.

J Sex Med. 2009 Nov;6(11):3166-76. doi: 10.1111/j.1743-6109.2009.01456.x. Epub 2009 Aug 17.

PMID:
19694927
19.

Earliest time to onset of action leading to successful intercourse with vardenafil determined in an at-home setting: a randomized, double-blind, placebo-controlled trial.

Montorsi F, Padma-Nathan H, Buvat J, Schwaibold H, Beneke M, Ulbrich E, Bandel TJ, Porst H; Vardenafil Study Group.

J Sex Med. 2004 Sep;1(2):168-78.

PMID:
16422971
20.

Penetration and maintenance of erection with vardenafil: a time-from-dosing analysis.

Valiquette L, Montorsi F, Hellstrom WJ, Giuliano F, Homering M, Taylor T, Eardley I; Vardenafil Study Group.

Can J Urol. 2005 Jun;12(3):2687-98; discussion 2699.

PMID:
16011816

Supplemental Content

Support Center